Rocket Lab (NASDAQ:RKLB) Stock Price Up 3% – Should You Buy?

Rocket Lab Corporation (NASDAQ:RKLB)’s share price was up 3% during mid-day trading on Tuesday . The company traded as high as $72.50 and last traded at $71.98. Approximately 21,171,751 shares changed hands during trading, a decline of 9% from the average daily volume of 23,166,977 shares. The stock had previously closed at $69.89.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Strong analyst support and major catalysts: Cantor Fitzgerald reaffirmed its Overweight rating and $122 price target, identifying the Neutron launch as Rocket Lab’s most important upcoming catalyst. The firm also cited the Iridium transaction, launch execution, and the company’s record $2.36 billion backlog. Rocket Lab Analyst Calls Neutron Launch the Most Material Catalyst
• Positive Sentiment: Broader commercial ambitions: CEO Peter Beck emphasized that Rocket Lab is building an integrated space business spanning launch, spacecraft, and services—not just the Electron rocket. The Iridium deal could expand its customer base and recurring space-systems revenue while strengthening its position as a potential SpaceX alternative. Rocket Lab’s SpaceX Playbook
• Positive Sentiment: Execution and technology progress: Rocket Lab continues to report successful Electron missions, including a Synspective launch that preserved its perfect record for that customer. Its optical systems and space-awareness technologies also broaden exposure to defense and national-security markets. Can Rocket Lab’s Optical Systems Boost Its Growth Opportunities?
• Neutral Sentiment: Technical momentum: The stock has rebounded from support near $60 and moved above a historically bullish trendline, encouraging momentum-oriented investors. Nevertheless, it remains below its longer-term moving average and has underperformed the broader market over six months. Rocket Lab Stock Breaks Above Key Trendline
• Negative Sentiment: Significant dilution: Rocket Lab sold approximately $1.9 billion of new stock—about 5% of the company—to help fund the $8.1 billion Iridium transaction without taking on substantial debt. Further share-count growth may reduce per-share upside for existing investors. Rocket Lab Sold New Stock to Pay for Iridium
• Negative Sentiment: Valuation and profitability concerns: Critics argue that Rocket Lab’s premium valuation already reflects much of its expected commercial growth, while the company’s path to profitability is lengthening. The stock’s substantial losses make successful Neutron development and execution especially important. Wall Street Thinks Rocket Lab Is a Buy

Analyst Ratings Changes

RKLB has been the topic of a number of analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Rocket Lab in a research note on Friday, July 17th. Raymond James Financial assumed coverage on shares of Rocket Lab in a report on Friday, September 11th. They set an “outperform” rating and a $80.00 price target on the stock. Piper Sandler began coverage on shares of Rocket Lab in a research note on Wednesday, July 15th. They set a “neutral” rating and a $83.00 target price on the stock. Berenberg Bank initiated coverage on Rocket Lab in a report on Wednesday, September 2nd. They set a “buy” rating and a $83.00 price target on the stock. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $130.00 price objective on shares of Rocket Lab in a research report on Tuesday, August 11th. Four equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.32.

Rocket Lab Price Performance

The company has a market capitalization of $43.07 billion, a P/E ratio of -266.58 and a beta of 2.60. The stock’s fifty day simple moving average is $69.42 and its 200-day simple moving average is $84.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. On average, equities analysts forecast that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Adam C. Spice sold 140,157 shares of Rocket Lab stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $62.63, for a total value of $8,778,032.91. Following the completion of the transaction, the chief financial officer directly owned 1,155,967 shares of the company’s stock, valued at $72,398,213.21. The trade was a 10.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 7,754 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $539,911.02. Following the sale, the senior vice president directly owned 256,951 shares in the company, valued at $17,891,498.13. This trade represents a 2.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 3,536,371 shares of company stock valued at $303,442,641. 8.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Rocket Lab

A number of institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new position in shares of Rocket Lab in the 2nd quarter valued at $4,124,970,000. Capital World Investors grew its stake in shares of Rocket Lab by 12.0% during the fourth quarter. Capital World Investors now owns 16,200,726 shares of the rocket manufacturer’s stock worth $1,130,172,000 after purchasing an additional 1,738,623 shares during the period. Bank of New York Mellon Corp bought a new stake in Rocket Lab in the second quarter valued at about $245,764,000. Geode Capital Management LLC increased its holdings in Rocket Lab by 10.1% in the fourth quarter. Geode Capital Management LLC now owns 9,004,724 shares of the rocket manufacturer’s stock valued at $626,605,000 after purchasing an additional 825,158 shares during the last quarter. Finally, Norges Bank acquired a new position in Rocket Lab in the fourth quarter valued at about $341,036,000. 71.78% of the stock is owned by institutional investors.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space company that provides launch services and space systems for commercial, civil and national security customers. The company develops and operates launch vehicles, spacecraft and satellite components, with activities spanning the design, manufacture and operation of space hardware.

Rocket Lab’s Electron rocket is a small-lift orbital launch vehicle designed to deploy small satellites. The company also develops HASTE, a suborbital test vehicle based on Electron technology, and is developing Neutron, a larger reusable launch vehicle intended to support a broader range of missions.